Related Experiment Videos
A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the
I Claassen1, N Van Rooijen, E Claassen
1Department of Immunology, TNO Medical Biological Laboratory, Rijswijk, The Netherlands.
Abstract:
In this study we present a new method for the elimination of mononuclear phagocytic cells from cell suspensions. By making use of liposome-encapsulated dichloromethylene diphosphonate we were able to effectively remove macrophages from spleen cell suspensions. This effect was not observed when using the free drug or control (PBS) liposomes. The use of this procedure has no effect on other cell types, as measured by growth, protein production, antigen presentation and antigen specific T cell proliferation, though PBS liposomes in very high doses were able to inhibit antigen presentation. The finding that lymphocytes are not affected by the liposome encapsulated drug suggests that the observed loss of lymphocytes in vivo, after intravenous dichloromethylene diphosphonate liposome treatment, may be due to damage inflicted by lysosomal enzymes released from dying macrophages. This method permits the removal of both macrophages and monocytes from heterogeneous cell populations (i.e., blood, lymphoid tissue suspension) in vitro with a very high rate of reliability. With the concentrations and incubation time used, no negative effects on other cell types were observed.
Insights
Researchers developed a novel method using liposome-encapsulated dichloromethylene diphosphonate to eliminate macrophages from cell suspensions. This technique effectively removes mononuclear phagocytic cells without harming other cell types, offering a reliable in vitro method.
Area of Science:
- Immunology
- Cell Biology
- Drug Delivery Systems
Background:
- Mononuclear phagocytic cells, such as macrophages and monocytes, play crucial roles in immune responses and tissue homeostasis.
- Selective elimination of these cells from heterogeneous cell populations is essential for various research applications, including immunology and cell therapy.
- Existing methods for cell depletion can lack specificity or affect non-target cell populations.
Purpose of the Study:
- To develop and validate a novel method for the selective elimination of mononuclear phagocytic cells from cell suspensions.
- To assess the efficacy and specificity of liposome-encapsulated dichloromethylene diphosphonate for macrophage depletion.
- To investigate the impact of this method on other immune cell types and cellular functions.
Main Methods:
- Utilized liposome-encapsulated dichloromethylene diphosphonate to treat spleen cell suspensions.
- Compared the effects of encapsulated drug with free drug and control liposomes (PBS liposomes).
- Assessed the impact on cell viability, growth, protein production, antigen presentation, and T cell proliferation.
Main Results:
- Liposome-encapsulated dichloromethylene diphosphonate effectively removed macrophages from spleen cell suspensions.
- No significant adverse effects were observed on other cell types, including lymphocytes, in terms of growth, protein production, or T cell proliferation.
- Free drug or control liposomes did not exhibit the same selective depletion effect; high doses of PBS liposomes showed some inhibition of antigen presentation.
Conclusions:
- Liposome-encapsulated dichloromethylene diphosphonate provides a reliable and specific method for in vitro depletion of macrophages and monocytes from heterogeneous cell populations.
- The observed lymphocyte loss in vivo following similar treatment may be attributed to lysosomal enzymes released from dying macrophages.
- This technique offers a valuable tool for immunological research by enabling precise manipulation of cell populations without compromising other immune cells.